CDC37 and breast cancer: At this point it is important to note that in this assay, the effect of the anti-Cdc37 antibody is directed towards cell invasion and not towards cell proliferation, since very low (<7%) BrdU incorporation was observed in both human breast cancer cell cultures treated as above with no apparent differences between the different experimental conditions (data not shown).